Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Cell death: critical control points.
|
Cell
|
2004
|
22.56
|
2
|
An inhibitor of Bcl-2 family proteins induces regression of solid tumours.
|
Nature
|
2005
|
22.40
|
3
|
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.
|
Nat Genet
|
2001
|
13.79
|
4
|
Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics.
|
Cancer Cell
|
2002
|
11.09
|
5
|
BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis.
|
Science
|
2003
|
9.55
|
6
|
Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix.
|
Science
|
2004
|
7.63
|
7
|
Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1.
|
Nature
|
2003
|
6.78
|
8
|
A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis.
|
Dev Cell
|
2002
|
5.45
|
9
|
VDAC2 inhibits BAK activation and mitochondrial apoptosis.
|
Science
|
2003
|
4.92
|
10
|
BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis.
|
Nature
|
2003
|
4.80
|
11
|
Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells.
|
Science
|
2005
|
4.75
|
12
|
Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia.
|
Proc Natl Acad Sci U S A
|
2005
|
4.63
|
13
|
Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1alpha.
|
Science
|
2006
|
4.46
|
14
|
A spatially and temporally restricted mouse model of soft tissue sarcoma.
|
Nat Med
|
2007
|
3.96
|
15
|
A stapled BID BH3 helix directly binds and activates BAX.
|
Mol Cell
|
2006
|
3.86
|
16
|
Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification.
|
Cancer Cell
|
2003
|
3.75
|
17
|
Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability.
|
Cell
|
2002
|
3.72
|
18
|
Taspase1: a threonine aspartase required for cleavage of MLL and proper HOX gene expression.
|
Cell
|
2003
|
3.35
|
19
|
Apoptosis in the development and maintenance of the immune system.
|
Nat Immunol
|
2003
|
3.02
|
20
|
Proapoptotic BAX and BAK regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum.
|
Proc Natl Acad Sci U S A
|
2004
|
3.00
|
21
|
Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis.
|
Dev Cell
|
2002
|
2.96
|
22
|
Dual role of proapoptotic BAD in insulin secretion and beta cell survival.
|
Nat Med
|
2008
|
2.78
|
23
|
Phosphorylation of BCL-2 regulates ER Ca2+ homeostasis and apoptosis.
|
EMBO J
|
2004
|
2.77
|
24
|
Reactivation of the p53 tumor suppressor pathway by a stapled p53 peptide.
|
J Am Chem Soc
|
2007
|
2.71
|
25
|
Proteolytic cleavage of MLL generates a complex of N- and C-terminal fragments that confers protein stability and subnuclear localization.
|
Mol Cell Biol
|
2003
|
2.66
|
26
|
Mechanisms of cytochrome c release by proapoptotic BCL-2 family members.
|
Biochem Biophys Res Commun
|
2003
|
2.65
|
27
|
Bad-deficient mice develop diffuse large B cell lymphoma.
|
Proc Natl Acad Sci U S A
|
2003
|
2.54
|
28
|
Essential role of BAX,BAK in B cell homeostasis and prevention of autoimmune disease.
|
Proc Natl Acad Sci U S A
|
2005
|
2.43
|
29
|
Survival factor-induced extracellular signal-regulated kinase phosphorylates BIM, inhibiting its association with BAX and proapoptotic activity.
|
Proc Natl Acad Sci U S A
|
2004
|
2.36
|
30
|
Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation.
|
Blood
|
2003
|
2.35
|
31
|
A role for proapoptotic BID in the DNA-damage response.
|
Cell
|
2005
|
2.30
|
32
|
Proteolysis of MLL family proteins is essential for taspase1-orchestrated cell cycle progression.
|
Genes Dev
|
2006
|
2.20
|
33
|
cdx4 mutants fail to specify blood progenitors and can be rescued by multiple hox genes.
|
Nature
|
2003
|
2.16
|
34
|
p53 controls radiation-induced gastrointestinal syndrome in mice independent of apoptosis.
|
Science
|
2009
|
2.11
|
35
|
An Mll-dependent Hox program drives hematopoietic progenitor expansion.
|
Curr Biol
|
2004
|
2.10
|
36
|
A novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth.
|
Cancer Cell
|
2002
|
2.09
|
37
|
Definitive hematopoiesis requires the mixed-lineage leukemia gene.
|
Dev Cell
|
2004
|
2.09
|
38
|
Antiapoptotic BCL-2 is required for maintenance of a model leukemia.
|
Cancer Cell
|
2004
|
1.92
|
39
|
FLT3 mutations in childhood acute lymphoblastic leukemia.
|
Blood
|
2003
|
1.91
|
40
|
BID regulation by p53 contributes to chemosensitivity.
|
Nat Cell Biol
|
2002
|
1.84
|
41
|
Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease.
|
EMBO J
|
2005
|
1.79
|
42
|
A pharmacologic inhibitor of the protease Taspase1 effectively inhibits breast and brain tumor growth.
|
Cancer Res
|
2011
|
1.74
|
43
|
Proapoptotic BID is required for myeloid homeostasis and tumor suppression.
|
Genes Dev
|
2003
|
1.70
|
44
|
Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival.
|
Blood
|
2007
|
1.64
|
45
|
Activation of BAD by therapeutic inhibition of epidermal growth factor receptor and transactivation by insulin-like growth factor receptor.
|
J Biol Chem
|
2002
|
1.62
|
46
|
Inhibition of both the extrinsic and intrinsic death pathways through nonhomotypic death-fold interactions.
|
Mol Cell
|
2004
|
1.62
|
47
|
Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.
|
Cancer Res
|
2003
|
1.55
|
48
|
Oligomeric Bax is a component of the putative cytochrome c release channel MAC, mitochondrial apoptosis-induced channel.
|
Mol Biol Cell
|
2005
|
1.55
|
49
|
Uncleaved TFIIA is a substrate for taspase 1 and active in transcription.
|
Mol Cell Biol
|
2006
|
1.51
|
50
|
The BCL2A1 gene as a pre-T cell receptor-induced regulator of thymocyte survival.
|
J Exp Med
|
2005
|
1.46
|
51
|
The role of MLL in hematopoiesis and leukemia.
|
Curr Opin Hematol
|
2002
|
1.42
|
52
|
Bax channel inhibitors prevent mitochondrion-mediated apoptosis and protect neurons in a model of global brain ischemia.
|
J Biol Chem
|
2005
|
1.37
|
53
|
Traumatic brain injury in mice deficient in Bid: effects on histopathology and functional outcome.
|
J Cereb Blood Flow Metab
|
2006
|
1.34
|
54
|
Switching mechanisms of cell death in mdm2- and mdm4-null mice by deletion of p53 downstream targets.
|
Cancer Res
|
2003
|
1.32
|
55
|
Regulation of endoplasmic reticulum Ca2+ dynamics by proapoptotic BCL-2 family members.
|
Biochem Pharmacol
|
2003
|
1.30
|
56
|
Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia.
|
Blood
|
2002
|
1.30
|
57
|
A membrane-targeted BID BCL-2 homology 3 peptide is sufficient for high potency activation of BAX in vitro.
|
J Biol Chem
|
2006
|
1.26
|
58
|
Conformational changes in BID, a pro-apoptotic BCL-2 family member, upon membrane binding. A site-directed spin labeling study.
|
J Biol Chem
|
2004
|
1.20
|
59
|
Bax-dependent spermatogonia apoptosis is required for testicular development and spermatogenesis.
|
Biol Reprod
|
2002
|
1.18
|
60
|
MLL-rearranged leukemias: insights from gene expression profiling.
|
Semin Hematol
|
2003
|
1.16
|
61
|
Proapoptotic BAX and BAK control multiple initiator caspases.
|
EMBO Rep
|
2005
|
1.13
|
62
|
PP2A regulates BCL-2 phosphorylation and proteasome-mediated degradation at the endoplasmic reticulum.
|
J Biol Chem
|
2006
|
1.13
|
63
|
Ligand activation of the aromatic hydrocarbon receptor transcription factor drives Bax-dependent apoptosis in developing fetal ovarian germ cells.
|
Endocrinology
|
2002
|
1.12
|
64
|
Role of proapoptotic BAX in propagation of Chlamydia muridarum (the mouse pneumonitis strain of Chlamydia trachomatis) and the host inflammatory response.
|
J Biol Chem
|
2002
|
1.10
|
65
|
p600, a unique protein required for membrane morphogenesis and cell survival.
|
Proc Natl Acad Sci U S A
|
2005
|
1.09
|
66
|
The VDAC2-BAK rheostat controls thymocyte survival.
|
Sci Signal
|
2009
|
1.08
|
67
|
Loss of Bax alters tumor spectrum and tumor numbers in ARF-deficient mice.
|
Cancer Res
|
2002
|
1.05
|
68
|
Bax, caspase-2, and caspase-3 are required for ovarian follicle loss caused by 4-vinylcyclohexene diepoxide exposure of female mice in vivo.
|
Endocrinology
|
2003
|
1.04
|
69
|
Enhanced oligodendrocyte survival after spinal cord injury in Bax-deficient mice and mice with delayed Wallerian degeneration.
|
J Neurosci
|
2003
|
1.04
|
70
|
Effects of cytochrome c on the mitochondrial apoptosis-induced channel MAC.
|
Am J Physiol Cell Physiol
|
2003
|
0.97
|
71
|
BAD is a pro-survival factor prior to activation of its pro-apoptotic function.
|
J Biol Chem
|
2004
|
0.94
|
72
|
Cell death induced by granzyme C.
|
Blood
|
2002
|
0.93
|
73
|
Untangling the web: mitochondrial fission and apoptosis.
|
Dev Cell
|
2004
|
0.85
|
74
|
Caspase regulation of genotoxin-induced neural precursor cell death.
|
J Neurosci Res
|
2003
|
0.83
|
75
|
Genomic approaches to the pathogenesis and treatment of acute lymphoblastic leukemias.
|
Curr Opin Hematol
|
2002
|
0.83
|
76
|
Proapoptotic histone H1.2 induces CASP-3 and -7 activation by forming a protein complex with CYT c, APAF-1 and CASP-9.
|
FEBS Lett
|
2007
|
0.83
|
77
|
Function of BID -- a molecule of the bcl-2 family -- in ischemic cell death in the brain.
|
Eur Surg Res
|
2002
|
0.83
|
78
|
A BAX/BAK and cyclophilin D-independent intrinsic apoptosis pathway.
|
PLoS One
|
2012
|
0.80
|
79
|
Comparison of human genomics and genetic models of cancer to identify novel therapeutic targets.
|
Cell Cycle
|
2003
|
0.75
|